Almost 5 000 persons world-wide have endorsed the petition to WHO/IARC to evaluate all scientific evidence and classify RF/EMF as human carcinogen, Group I. The petition is still open on Internet for those who want to sign it; follow this link. The joint statement is as follows:
We—the undersigned organizations, doctors, and scientists—wholeheartedly support the scientific findings of a connection between cancer and RF/EMF radiation. For the sanctity of human life, especially our children, we respectfully request that:
- WHO/IARC immediately conducts the appropriate scientific review within IARC to move RF/EMF radiation from its current class 2B to class 1, known carcinogen based on review of the complete scientific database.
- As is the policy of the WHO with Smoking/Cancer related issues, we respectfully request that the WHO and IARC not permit any conflicts of interests amongst the scientists, doctors, policy making/administrating officials, or anyone serving in any other capacity determining classifications of carcinogenicity and policy decisions regarding EMFs and Cancer.
- Specifically we respectfully request that any scientist, doctor, policy making/administrating official, or anyone serving in any capacity in WHO and IARC not receive now or in the near future any monetary compensation from the wireless industry or any company that produces products that emit or receive RF radiation or benefit from such products or companies – in the form of research grants, consulting fees or any other form of compensation including payments to any relative of the scientist or colleague in close association.
We respectfully request that these conflicts be vehemently policed and monitored to maintain the integrity of the classifications, assure absolute transparency and ensure safety of the public.
According to Dr. Lennart Hardell, MD, PhD, and oncologist:
“Based on the Hill criteria, glioma and acoustic neuroma should be considered to be caused by RF-EMF emissions from wireless phones and regarded as carcinogenic to humans, classifying it as group 1 according to the IARC classification. Current guidelines for exposure need to be urgently revised.” http://www.ncbi.nlm.nih.gov/pubmed/24192496